The Psychiatric Drug Development Landscape

We are pleased to share our Psychiatric Drug Development Landscape Review, providing clear, data-driven insights into the modalities, targets, delivery systems, formulations, clinical trial trends, and key regulatory announcements, shaping the future of Psychiatric therapeutic development.

Discover where Psychiatric therapeutic activity is concentrating, and where opportunity for differentiation still exists.

The Psychiatric Drug Development Landscape Review

Psychiatric drug development remains a critical focus for biopharma, driven by significant unmet patient need, and the complexity of CNS disorders.

This Report Offers Insight Into:

  • Targets & Target Crowding: 5-HT2A leads the way for top targets investigated. Uncover the shared involvement of neural circuits and neurotransmitter systems across Psychiatric disorders.
  • Delivery Systems & Formulations: Nanoparticles make up 35% of non-viral delivery systems, highlighting efforts to improve brain penetration and pharmacokinetics.
  • Clinical Trial Trends: Trial initiations have accelerated since 2023. Discover the psychiatric disease indications and therapies dominating the trial landscape.
  • Recent & Upcoming Regulatory Announcements: Including COBENFYTM for schizophrenia, and SPRAVATO® for treatment-resistant depression.
Psychiatric Drug Development Landing Page Image

You May Also Be Interested In…

Learn More About Psychiatric

What is Beacon Psychiatric?
  • The Most Comprehensive Way to Search the Psychiatric Drug Development Landscape: Unique search ontologies based on Psychiatric drug and trial characteristics
  • Market Leading Approach to Psychiatric Preclinical & Clinical Data Curation: Manual curation of key Psychiatric research and development data points by Psychiatric research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Psychiatric company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Psychiatric Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search